Literature DB >> 11196563

Termination of spiral waves with biphasic shocks: role of virtual electrode polarization.

C Anderson1, N Trayanova, K Skouibine.   

Abstract

INTRODUCTION: This simulation study seeks to extend the virtual electrode polarization (VEP) theory for defibrillation to explain the success and failure of biphasic shocks. The goals of the study are to (1) provide insight into why optimal biphasic shocks have a lower voltage defibrillation threshold than monophasic shocks, (2) examine the mechanisms of biphasic shock failure and to determine whether they differ from those of monophasic shocks, and (3) study how the timing of biphasic shock delivery to a spiral wave affects voltage defibrillation threshold. METHODS AND
RESULTS: A spiral wave is initiated in a bidomain representation of a 2-cm x 2-cm sheet of ventricular myocardium. The model incorporates nonuniform fiber curvature, membrane kinetics suitable for high-strength shocks, and electroporation. A spatially uniform extracellular field is delivered by line electrodes. The shock establishes VEP that dictates the postshock activity in the tissue. Our results demonstrate that the second phase of biphasic shocks leaves the tissue with substantially smaller postshock excitable gap, thus eliminating the majority of the substrate for reinitiation of reentrant activity. Further, the occurrence of break excitations for weaker biphasic shocks indicates that the mechanisms for biphasic shock failure are more complex than for monophasic shocks. Biphasic voltage defibrillation thresholds range from 8 to 16 V/cm, depending on the position of the spiral wave. An increase in the amount of preshock excitable gap leads to an increase in voltage defibrillation threshold.
CONCLUSION: This study demonstrates the importance of VEP and its interaction with preshock activity in the success and failure of biphasic defibrillation shocks.

Entities:  

Mesh:

Year:  2000        PMID: 11196563     DOI: 10.1046/j.1540-8167.2000.01386.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

1.  Tunnel propagation of postshock activations as a hypothesis for fibrillation induction and isoelectric window.

Authors:  Takashi Ashihara; Jason Constantino; Natalia A Trayanova
Journal:  Circ Res       Date:  2008-01-24       Impact factor: 17.367

2.  Polarity reversal lowers activation time during diastolic field stimulation of the rabbit ventricles: insights into mechanisms.

Authors:  M M Maleckar; M C Woods; V Y Sidorov; M R Holcomb; D N Mashburn; J P Wikswo; N A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

3.  Electric field perturbations of spiral waves attached to millimeter-size obstacles.

Authors:  Joshua Cysyk; Leslie Tung
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

4.  Tunnel propagation following defibrillation with ICD shocks: hidden postshock activations in the left ventricular wall underlie isoelectric window.

Authors:  Jason Constantino; Yun Long; Takashi Ashihara; Natalia A Trayanova
Journal:  Heart Rhythm       Date:  2010-03-25       Impact factor: 6.343

Review 5.  How computer simulations of the human heart can improve anti-arrhythmia therapy.

Authors:  Natalia A Trayanova; Kelly C Chang
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 6.  New insights into defibrillation of the heart from realistic simulation studies.

Authors:  Natalia A Trayanova; Lukas J Rantner
Journal:  Europace       Date:  2014-05       Impact factor: 5.214

7.  Capture of activation during ventricular arrhythmia using distributed stimulation.

Authors:  Jason M Meunier; Sanjiv Ramalingam; Shien-Fong Lin; Abhijit R Patwardhan
Journal:  J Interv Card Electrophysiol       Date:  2007-05-23       Impact factor: 1.900

Review 8.  Optimizing defibrillation waveforms for ICDs.

Authors:  Mark W Kroll; Charles D Swerdlow
Journal:  J Interv Card Electrophysiol       Date:  2007-06-01       Impact factor: 1.900

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.